Pular para o conteúdo
Merck
Todas as fotos(1)

Documentos Principais

MAB4383

Sigma-Aldrich

Anti-Nuclei Antibody, clone 3E1.3

clone 3E1.3, Chemicon®, from mouse

Sinônimo(s):

Anti-Nuclei, Clone 3E1.3 Anti-Nuclei, Nuclei Detection Antibody

Faça loginpara ver os preços organizacionais e de contrato


About This Item

Código UNSPSC:
12352203
eCl@ss:
32160702
NACRES:
NA.41

fonte biológica

mouse

Nível de qualidade

forma do anticorpo

purified antibody

tipo de produto de anticorpo

primary antibodies

clone

3E1.3, monoclonal

reatividade de espécies

human

não deve reagir com

mouse

fabricante/nome comercial

Chemicon®

técnica(s)

flow cytometry: suitable
immunocytochemistry: suitable
immunohistochemistry: suitable

entrada

sample type neural stem cell(s)

Isotipo

IgG1

Condições de expedição

wet ice

modificação pós-traducional do alvo

unmodified

Descrição geral

Stains nuclei of all human cell types giving a diffuse nuclear staining pattern. Chromosomes are negatively stained in metaphase cells.

Imunogênio

Purified Recombinant Human Nuclei

Aplicação

Anti-Nuclei Antibody, clone 3E1.3 detects level of Nuclei & has been published & validated for use in FC, IC, IH.
Research Category
Stem Cell Research
Research Sub Category
Neural Stem Cells

forma física

Format: Purified
Liquid in PBS with 0/1% sodium azide

Armazenamento e estabilidade

Maintain refrigerated at 2-8°C in undiluted aliquots for up to 12 months.

Outras notas

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

Informações legais

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Exoneração de responsabilidade

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Não está encontrando o produto certo?  

Experimente o nosso Ferramenta de seleção de produtos.

Código de classe de armazenamento

12 - Non Combustible Liquids

Classe de risco de água (WGK)

WGK 2

Ponto de fulgor (°F)

Not applicable

Ponto de fulgor (°C)

Not applicable


Certificados de análise (COA)

Busque Certificados de análise (COA) digitando o Número do Lote do produto. Os números de lote e remessa podem ser encontrados no rótulo de um produto após a palavra “Lot” ou “Batch”.

Já possui este produto?

Encontre a documentação dos produtos que você adquiriu recentemente na biblioteca de documentos.

Visite a Biblioteca de Documentos

N Uchida et al.
Proceedings of the National Academy of Sciences of the United States of America, 97(26), 14720-14725 (2000-12-20)
Stem cells, which are clonogenic cells with self-renewal and multilineage differentiation properties, have the potential to replace or repair damaged tissue. We have directly isolated clonogenic human central nervous system stem cells (hCNS-SC) from fresh human fetal brain tissue, using
Design of a Tumorigenicity Test for Induced Pluripotent Stem Cell (iPSC)-Derived Cell Products.
Kawamata, S; Kanemura, H; Sakai, N; Takahashi, M; Go, MJ
Journal of clinical medicine null
Julia K Bialek-Waldmann et al.
Molecular therapy. Methods & clinical development, 21, 621-641 (2021-06-08)
Acute myeloid leukemia (AML) patients with minimal residual disease and receiving allogeneic hematopoietic stem cell transplantation (HCT) have poor survival. Adoptive administration of dendritic cells (DCs) presenting the Wilms tumor protein 1 (WT1) leukemia-associated antigen can potentially stimulate de novo
Charles Capdeville et al.
Life science alliance, 5(6) (2022-03-18)
The composition of the plasma membrane (PM)-associated proteome of tumor cells determines cell-cell and cell-matrix interactions and the response to environmental cues. Whether the PM-associated proteome impacts the phenotype of Medulloblastoma (MB) tumor cells and how it adapts in response
Jyoti Kode et al.
The Indian journal of medical research, 139(4), 585-597 (2014-06-14)
In current era of limb-salvage therapy, pasteurization of bone sarcomas is receiving growing attention as a potential extracorporeal treatment and cost-effective alternative to allografts and radiation before surgical reimplantation. Detailed in vitro and in vivo pre-clinical study to evaluate efficacy

Nossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.

Entre em contato com a assistência técnica